Recent settlements related to claims against advertising and pharmaceutical companies involved in the opioid crisis are providing hope for accountability and funding for treatment. However, concerns remain about the impact of these settlements on the epidemic, as past lawsuits did not lead to significant changes in marketing practices. Studies have shown a link between aggressive marketing of opioids and overdose deaths, prompting the need for education for prescribers on addiction risk assessment and management. Additionally, policies around marketing practices for addictive medications should be reconsidered to prevent history from repeating itself. It is crucial for clinicians and policymakers to address the root causes of the opioid crisis to prevent future harm.
Source link
How Marketing Fueled the Opioid Overdose Crisis and What We Can Learn From It
